COMMUNIQUÉS West-GlobeNewswire

RxSight, Inc. To Participate in the Truist Securities Medtech Conference
05/06/2024
ALISO VIEJO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced [...]
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
05/06/2024
VANCOUVER, British Columbia, June 05, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the Goldman [...]
Ventyx Biosciences Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory Markers
05/06/2024
VTX3232 demonstrated improvements in body weight, systemic inflammatory biomarkers and cardiometabolic parameters in diet-induced obesity (DIO) mice Additive effects were observed for VTX3232 in combination with the GLP [...]
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/06/2024
WESTLAKE VILLAGE, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
CBIH and Vita Biotech Forge Alliance to Propel Clinical Studies Forward
05/06/2024
HOUSTON, June 05, 2024 (GLOBE NEWSWIRE) -- Vita Biotech Research has entered into a significant partnership with Cannabis Bioscience International Holdings (OTCMKTS: CBIH), to fund the clinical data collection efforts [...]
Oxford Treatment Center Launches New Christian-Based Treatment Program for Those Struggling with Drug and Alcohol Addiction
05/06/2024
ETTA, Miss., June 05, 2024 (GLOBE NEWSWIRE) -- Oxford Treatment Center, a leading addiction treatment provider, has introduced a new Christian-based treatment program, offering patients the option to have a spiritually [...]
Dr María José Torres, responsable du département d’allergologie à l’Hôpital universitaire régional de Malaga, nouvelle présidente de l’EAACI
05/06/2024
L’EAACI met l’accent sur la santé planétaire en tant qu’élément clé de son programme de recherche VALENCE, Espagne, 05 juin 2024 (GLOBE NEWSWIRE) -- Le Congrès 2024 de l’EAACI, un forum rassemblant des experts dans les [...]
New Nymbl Science Report Asks: Are Falls an Invisible Epidemic?
05/06/2024
Digital health leader shares results from large-scale studies that prove preventive programs help mitigate fall risks DENVER, June 05, 2024 (GLOBE NEWSWIRE) -- Nymbl Science , a digital health provider and leader in [...]
Genmab to Participate in a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference
05/06/2024
Media Release COPENHAGEN, Denmark; June 05, 2024 Genmab A/S (Nasdaq: GMAB ) announced today that its Chief Financial Officer Anthony Pagano and Chief Operating Officer Anthony Mancini will participate in a fireside chat [...]
Intercept Presents New Data on the Results of OCA-Bezafibrate Combination Therapy in PBC After Six Months of Treatment in Late-Breaking Poster Presentation at EASL Congress 2024
05/06/2024
Results show combination of OCA 5-10 mg and bezafibrate 400 mg normalizes multiple serum biomarkers that are associated with improved transplant-free and decompensation-free survival in PBC MORRISTOWN, N.J., June 05, [...]
InflaRx Hosts R&D Event Highlighting the Promise of INF904
05/06/2024
Thought leaders in complement inhibition, chronic spontaneous urticaria (CSU) and hidradenitis suppurativa (HS) provide compelling new insights into the strong development rationales, potential differentiation and [...]
Monthly information related to total number of voting rights and shares composing the share capital – May 31, 2024
05/06/2024
Article 223-16 of general regulation of French Autorité des Marchés Financiers Listing market: Euronext Paris (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM) Website : www.phaxiam.com Date Total of shares [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 mai 2024
05/06/2024
Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Place de cotation : Euronext Paris (Compartiment C - Code ISIN : FR001400K4B1 – Symbole : PHXM) Site web : www.phaxiam.com Date Nombre total d’ [...]
Late Breaking Poster Shows a Novel Oral Insulin Sensitizer Azemiglitazone (MSDC-0602K) Could Substantially Preserve Lean Muscle in Combination with Weight-Loss GLP1s
05/06/2024
Azemiglitazone (MSDC-0602K) working through a newly identified mitochondrial target adds cardiometabolic benefit to GLP-1 receptor agonists Benefit includes preservation of lean muscle, which could expand the usefulness [...]
New Findings Revealed on Kyolic Aged Garlic Extract Research at 7th Annual International Garlic Symposium
05/06/2024
MUNICH, June 05, 2024 (GLOBE NEWSWIRE) -- The latest research on Wakunaga of America ’s Aged Garlic Extract (AGE) was presented at the 7th International Garlic Symposium : Frontiers of Garlic Research in Health [...]
SupplyCopia Unveils Groundbreaking Real-time Smart Agent, Powered by AI for On-demand Analytics Needed by Healthcare Organizations
05/06/2024
For the first time, AI will be used to deliver instant answers based on actual data sets from individual health systems and aggregated industry data BRIDGEWATER, N.J., June 05, 2024 (GLOBE NEWSWIRE) -- SupplyCopia, a [...]
XTL Entered Definitive Agreement to Acquire The Social Proxy
05/06/2024
expands its IP portfolio to AI Web Data The Social Proxy is a web data AI company developing and powering an IP based platform for AI & BI Applications at scale Secured $1.5 Million in a Private Placement RAMAT GAN [...]
Rett Syndrome Research Trust Launches Roadmap to Cures to Advance Next-Generation Genetic Medicines into Clinical Trials
05/06/2024
Roadmap to Cures is an initiative that seeks to raise $40M over the next four years to advance genetic medicine innovation for Rett syndrome TRUMBULL, Conn., June 05, 2024 (GLOBE NEWSWIRE) -- Rett Syndrome Research [...]
Osteal Therapeutics Closes $50M Series D Financing to Support Approval and Commercial Launch of Lead Candidate
05/06/2024
Financing led by Zimmer Biomet with participation from existing investors Johnson & Johnson Innovation – JJDC, Inc., Gideon Strategic Partners, and HM Capital. Proceeds will support NDA submission and commercial [...]

Pages